Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Paratus Clinical operates a network of wholly owned clinical research sites in Australia focused on efficient participant recruitment and rapid study start-up. The company has supported over 100 awarded clinical trials for pharmaceutical, biotechnology, CROs, medical device companies, and academic institutions. It specializes in fast HREC submissions and streamlined governance to accelerate trial timelines. No direct drug development or proprietary pipeline—acts as an enabler for sponsors’ pipelines. Average HREC approval time reported at 38 business days. Experience includes first-in-human studies and vaccine trials.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Paratus Clinical.